Combe announces launch of Preventeza Emergency Contraceptive and campaign

Combe Inc., the makers of Vagisil^®, today announced the launch of its Preventeza Emergency Contraceptive (levonorgestrel tablet, 1.5 mg) #WeAre1in2 campaign to showcase solidarity around women's reproductive rights. To demonstrate its commitment to helping women learn more about emergency contraception (EC), the Company is planning to give away up to $1 million worth of free product via the launch of its "Buy One Get One or Give One (BoGoGo)" product campaign where women who purchase Preventeza on Vagisil.com will have the option to get a second one for free to either keep on hand or to give to another woman in their life.

New Preventeza by Vagisil, available online or over-the-counter (OTC) as a single tablet, takes the panic out of a stressful moment, and is a proven option to help women prevent pregnancy before it starts by using the same ingredient as most birth control pills, just at a higher dose. By keeping Preventeza on hand, women can always be prepared and in control.

"We are thrilled about the BoGoGo promotion as it provides us with the opportunity to educate women about the need for and the importance of access to emergency contraception (EC). Moreover, it remains shocking to us that while 1 in 2 women may need an EC in their lifetime, only 10 percent of women have actually used it," said Keech Combe Shetty, CEO of Vagisil. "This is why we are giving away up to $1 million worth of Preventeza as it aligns with our mission at Vagisil to empower women to take ownership of their reproductive health without shame."

Preventeza's BoGoGo promotion is available nationwide and can be activated at checkout online at Vagisil.com. In parallel, the Company is launching the #WeAre1in2 campaign on social media that is aimed at increasing awareness of the fact that 1 in 2 women may need EC in their lifetime due to the risk of unintended pregnancies. People are encouraged to showcase their solidarity using #WeAre1in2 on social media.

"It is an important time in the history of our country for women to gather together on critical issues related to reproductive health. The fact that 45 percent of pregnancies remain unplanned or mistimed clearly demonstrates the need for education so women can understand that there are safe and effective tools that serve as back-ups for regular birth control in case of unprotected sex or when birth control fails. In addition to practicing safe sex, there are EC options, such as Vagisil's Preventeza, available to all women of reproductive age," said Logan Levkoff, PhD, MS, an internationally recognized expert on sexuality and relationships. "I am proud that Preventeza is launching a dialogue on this timely movement that will help to differentiate myths versus facts about EC while increasing access for all women."

Preventeza is brought to you by the makers of Vagisil, a trusted women's health brand, that encourages women to talk about health topics they are uncomfortable discussing, provides facts and resources to help educate, and thereby reduces the shame that still exists around vaginal and sexual health.

How Preventeza Works

Preventeza can be taken within 72 hours (three days) after unprotected sex has occurred, yet is most effective the sooner it is taken. Preventeza works mainly by stopping the release of an egg from the ovary. Preventeza will not harm an existing pregnancy. Preventeza does not protect women from HIV infection (the virus that causes AIDS) and other sexually transmitted diseases (STDs).

When used as directed, Preventeza can significantly decrease the chance of a woman becoming pregnant after unprotected sex. Approximately seven out of every eight women who would have become pregnant will not after taking Preventeza.